Go Pro
→ Your book is inside (From Profits Run) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
$0.55
+5.9%		$0.57
$0.40
▼
$50.00
$6.73MN/A105,424 shs228,359 shs
INVO Fertility, Inc stock logo
IVF
INVO Fertility
$0.97
+0.2%		$1.27
$0.90
▼
$84.40
$2.23M2.3278,813 shs48,505 shs
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
$1.73
+5.2%		$6.94
$1.40
▼
$34.80
$1.47M-0.82204,463 shs65,180 shs
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
$0.59
+6.5%		$1.32
$0.45
▼
$513.00
$3.47M0.01446,778 shs233,548 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
0.00%+20.61%+3.62%-59.03%+54,899,900.00%
INVO Fertility, Inc stock logo
IVF
INVO Fertility
0.00%-8.34%-14.02%-39.08%-98.59%
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
0.00%-2.26%-47.89%-95.13%-99.22%
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
0.00%-6.90%-56.30%-78.31%-99.83%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
$0.55
+5.9%		$0.57
$0.40
▼
$50.00
$6.73MN/A105,424 shs228,359 shs
INVO Fertility, Inc stock logo
IVF
INVO Fertility
$0.97
+0.2%		$1.27
$0.90
▼
$84.40
$2.23M2.3278,813 shs48,505 shs
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
$1.73
+5.2%		$6.94
$1.40
▼
$34.80
$1.47M-0.82204,463 shs65,180 shs
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
$0.59
+6.5%		$1.32
$0.45
▼
$513.00
$3.47M0.01446,778 shs233,548 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
0.00%+20.61%+3.62%-59.03%+54,899,900.00%
INVO Fertility, Inc stock logo
IVF
INVO Fertility
0.00%-8.34%-14.02%-39.08%-98.59%
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
0.00%-2.26%-47.89%-95.13%-99.22%
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
0.00%-6.90%-56.30%-78.31%-99.83%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
2.00
Hold$5.00810.75% Upside
INVO Fertility, Inc stock logo
IVF
INVO Fertility
2.50
Moderate Buy$20.001,958.46% Upside
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
1.00
SellN/AN/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest MNDR, AIDX, NIVF, and IVF Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E-) ➝ Sell (E)
8/3/2026
INVO Fertility, Inc stock logo
IVF
INVO Fertility
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
7/24/2026
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
6/24/2026
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 8/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
$2.05M3.28N/AN/AN/A∞
INVO Fertility, Inc stock logo
IVF
INVO Fertility
$6.84M0.33N/AN/A$3.46 per share0.28
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
$7.65M0.19N/AN/A$14.19 per share0.12
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
$4.73M0.73N/AN/A$317.37 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
-$3.74M-$0.28N/AN/AN/AN/AN/AN/AN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
-$25.13M-$352.18N/AN/AN/A-183.75%-420.62%-45.21%N/A
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
-$3.38MN/AN/AN/AN/AN/AN/AN/AN/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
$9.88MN/AN/A0.02N/AN/AN/AN/A9/2/2026 (Estimated)

Latest MNDR, AIDX, NIVF, and IVF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/2/2026N/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
$6.06N/AN/AN/A$20.10 millionN/A
8/14/2026Q2 2026
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A-$0.26N/A-$0.26N/A$0.73 million
8/14/2026Q2 2026
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/A$0.35N/A$0.35N/A$2.18 million
6/22/2026Q1 2026
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/A-$3.38N/A-$3.38N/A$2.02 million
6/2/2026Q4 2025
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/A$4.18N/A$4.1840N/A$1.60 million
5/20/2026Q1 2026
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A-$0.28N/A-$0.28N/A$0.35 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/AN/AN/AN/AN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
N/AN/AN/AN/AN/A
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
N/AN/AN/AN/AN/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A
1.82
1.78
INVO Fertility, Inc stock logo
IVF
INVO Fertility
0.05
0.90
0.87
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
N/A
4.22
4.15
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
0.16
3.12
2.98

Institutional Ownership

CompanyInstitutional Ownership
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
N/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
12.02%
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
N/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
66.24%

Insider Ownership

CompanyInsider Ownership
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
29.80%
INVO Fertility, Inc stock logo
IVF
INVO Fertility
0.43%
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
N/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
31.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
20/20 Biolabs Inc stock logo
AIDX
20/20 Biolabs
1412.25 million8.60 millionN/A
INVO Fertility, Inc stock logo
IVF
INVO Fertility
102.30 million2.29 millionNo Data
Mobile-health Network Solutions stock logo
MNDR
Mobile-health Network Solutions
N/A850,000N/AN/A
NewGenIvf Group Limited stock logo
NIVF
NewGenIvf Group
N/A5.92 million4.04 millionN/A

Recent News About These Companies

NewGenIvf Group Limited Class A
August 1, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/NIVF
NewGen Provides Update on K25.ai Investment and Strengthened Financial Position
July 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/30/3336057/0/en/newgen-provides-update-on-k25-ai-investment-and-strengthened-financial-position.html
NewGenIVF Boosts Stake in K25.ai, Leveraging US$250 Million Valuation to Support Nasdaq Compliance
July 28, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/markets-news/Tipranks/3500771/newgenivf-boosts-stake-in-k25-ai-leveraging-us250-million-valuation-to-support-nasdaq-compliance/
NewGenIVF Group Limited: NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
July 27, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69132706-newgenivf-group-limited-newgen-to-acquire-additional-3-of-k25-ai-at-us-dollar-250-million-valuation-following-strong-community-beta-strengthening-market-c-399.htm
NewGen to Acquire Additional 3% of K25.ai at US$250 Million Valuation Following Strong Community Beta; Strengthening Market Cap Above US$5 Million
July 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/27/3333525/0/en/newgen-to-acquire-additional-3-of-k25-ai-at-us-250-million-valuation-following-strong-community-beta-strengthening-market-cap-above-us-5-million.html
NewGen’s Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai’s Valuation Reaches US$200 Million
July 23, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/newgen-s-strategic-pre-a-investment-in-k25-ai-doubles-in-value-as-k25-ai-s-valuation-reaches-us-200-million-1036356887
NewGen's Strategic Pre-A Investment in K25.ai Doubles in Value as K25.ai's Valuation Reaches US$200 Million
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332135/0/en/NewGen-s-Strategic-Pre-A-Investment-in-K25-ai-Doubles-in-Value-as-K25-ai-s-Valuation-Reaches-US-200-Million.html
K25.ai Secures Series A Investment with Strategic Support from Amber Group, Valuation Doubles to US$200 Million
July 23, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/k25ai-secures-series-a-investment-with-strategic-support-from-amber-group-valuation-doubles-to-us200-million-302833151.html
NewGen's Advanced Cytometry Platform Poised for Major UAE/GCC Expansion with Big Four Valuation of US$19 Million
July 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/06/3322444/0/en/newgen-s-advanced-cytometry-platform-poised-for-major-uae-gcc-expansion-with-big-four-valuation-of-us-19-million.html
NewGenIvf Group Limited Class A Ordinary Shares (NIVF) Insider Activity
June 27, 2026  |  nasdaq.comhttps://www.nasdaq.com/market-activity/stocks/nivf/insider-activity
NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization
June 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/22/3315284/0/en/newgen-issues-3-666-667-new-shares-in-connection-with-strategic-k25-ai-acquisition-reaches-milestone-of-us-7-6-million-market-capitalization.html
NewGenIVF Group Limited: NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
June 18, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-06/68804582-newgenivf-group-limited-newgen-increases-k25-ai-ownership-to-10-in-closed-pre-a-round-at-us-dollar-100-million-valuation-with-total-us-dollar-10-million-invested-399.htm
NewGen Increases K25.ai Ownership to 10% in Closed Pre-A Round at US$100 Million Valuation with Total US$10 Million Invested
June 18, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/18/3314164/0/en/newgen-increases-k25-ai-ownership-to-10-in-closed-pre-a-round-at-us-100-million-valuation-with-total-us-10-million-invested.html
NewGen Eliminates Convertible Note and Warrant Overhang with a Significant Investor, Enters Into Settlement Agreement Strengthening Capital Structure
June 16, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/16/3312571/0/en/newgen-eliminates-convertible-note-and-warrant-overhang-with-a-significant-investor-enters-into-settlement-agreement-strengthening-capital-structure.html
NewGenIvf Group Adds Four Independent Directors to Board in June 2026
June 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/newgenivf-group-adds-four-independent-directors-to-board-in-june-2026?utm_source=marketbeat.com&utm_medium=referral
NewGen Adds to K25.ai Investment as AI Prediction Market Push Deepens
June 6, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/crypto/articles/newgen-adds-k25-ai-investment-174100509.html
NewGenIVF Deepens Commitment to K25.ai with Additional $4 Million Investment
June 4, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/newgenivf-deepens-commitment-to-k25ai-with-additional-4-million-investment/ar-AA24QiqI
NewGen Doubles Down on K25.ai with Additional US$4 Million Stake and Adopts Digital Asset Treasury Strategy
June 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/04/3306728/0/en/newgen-doubles-down-on-k25-ai-with-additional-us-4-million-stake-and-adopts-digital-asset-treasury-strategy.html
NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Sells $68,253.60 in Stock
May 29, 2026  |  insidertrades.comhttps://www.insidertrades.com/alerts/nasdaq-nivf-insider-buying-and-selling-2026-05-29/
NewGen Executes Share Purchase Agreement and Obtains Exclusive APAC Agency Rights with K25.ai, an AI-Powered Prediction Market Led by Industry Veteran Andy Cheung
May 28, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/28/3302855/0/en/newgen-executes-share-purchase-agreement-and-obtains-exclusive-apac-agency-rights-with-k25-ai-an-ai-powered-prediction-market-led-by-industry-veteran-andy-cheung.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

20/20 Biolabs stock logo

20/20 Biolabs NASDAQ:AIDX

$0.55 +0.03 (+5.86%)
Closing price 08/14/2026 03:59 PM Eastern
Extended Trading
$0.56 +0.01 (+1.82%)
As of 08/14/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. We offer two families of lab tests, both under our OneTest brand: (i) OneTest for Cancer, a multi-cancer early detection, or MCED, blood test which has been our primary commercial focus and source of revenues since we wound down our COVID-19 testing business, and (ii) OneTest for Longevity, which measures inflammatory biomarkers, that we expect to launch in the first half of 2026. Both tests are run in our CAP (College of American Pathologists) accredited, CLIA (Clinical Laboratory Improvement Amendments) licensed laboratory in Gaithersburg, MD. That laboratory also hosts our Clinical Laboratory Innovation Accelerator, or CLIAx, which we believe is the country’s first shared CLIA laboratory for overseas diagnostics start-ups seeking to launch novel lab tests in the U.S. without the expense of establishing and operating their own, independent lab. As noted above, during the COVID-19 pandemic, we also provided COVID-19 viral testing using polymerase chain reaction, or PCR, analytical equipment in our clinical laboratory. Our legacy business also includes a pioneering field test kit for screening suspicious powders for bioterror agents known as BioCheck. As of the date of this prospectus, we generate revenue from three sources: OneTest for Cancer (primarily as a lab test in the U.S. but we also license our algorithms to overseas labs), BioCheck and from our CLIAx. For each of the nine months ended September 30, 2025 and 2024, sales of OneTest for Cancer accounted for approximately 87% of our revenues, sales of BioCheck accounted for approximately 9% of our revenues, and our CLIAx accounted for approximately 4% of our revenues. For the years ended December 31, 2024 and 2023, sales of OneTest for Cancer accounted for approximately 85% and 65% of our revenues, respectively, sales of BioCheck accounted for approximately 10% and 13% of our revenues, respectively, our CLIAx accounted for approximately 5% and 4% of our revenues, respectively, and COVID-19 testing accounted for approximately 0% and 18% of our revenues, respectively. Our principal executive offices are located in Gaithersburg, MD.

INVO Fertility stock logo

INVO Fertility NASDAQ:IVF

$0.97 +0.00 (+0.15%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$1.01 +0.04 (+3.95%)
As of 08/14/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Mobile-health Network Solutions stock logo

Mobile-health Network Solutions NASDAQ:MNDR

$1.73 +0.09 (+5.17%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$1.72 -0.01 (-0.87%)
As of 08/14/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mobile-health Network Solutions, an investment holding company, provides telehealth solutions in Singapore. The company operates in two segments, Telemedicine and Other Services, and Sale of Medicine and Medical Devices. It offers MaNaDr platform, a 360-degree healthcare ecosystem, which connects users and service providers through the range of healthcare services and product offerings that can be accessed through the mobile application and website. The company also provides a range of primary healthcare services, including general medical consultations, treatment and management of acute and chronic conditions in adults and children, vaccinations, and health screenings for work permit applications, as well as pre-employment health screening, children's health services, geriatric care services, and minor surgical procedures. In addition, it offers healthcare and wellness-related products through its online e-commerce platform; wholesale distribution of pharmaceutical products to clinics; and MaNaCare, a platform that provides a range of corporate healthcare and wellness services, including GP, specialist and allied healthcare panel services, tele-consultation services, in-person clinics, on-site health screening, and online marketplace and forum, as well as wellness programs to corporate customers. Further, the company develops IT systems on mobile phone and web portals; operates pharmacies, clinics, and drug stores; and offers beauty and other personal care services, as well as other general medical and health services. The company was founded in 2009 and is headquartered in Singapore.

NewGenIvf Group stock logo

NewGenIvf Group NASDAQ:NIVF

$0.59 +0.04 (+6.51%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$0.59 +0.01 (+1.09%)
As of 08/14/2026 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas